Summit Corporation Aktie
WKN DE: A115K3 / ISIN: GB00BN40HZ01
05.10.2024 17:12:00
|
Is Summit Therapeutics a Millionaire Maker?
The pharmaceutical industry is often about hitting home runs. Big pharmaceutical companies start small, and then a blockbuster product catapults them into the spotlight. Summit Therapeutics (NASDAQ: SMMT) has soared 1,000% over the past year on progress in developing a drug that could rival Merck's Keytruda, a product used to treat various cancers with over $25 billion in sales last year.Those who got in early have gotten rich. Is Summit Therapeutics still a potential millionaire maker?Or have investors gotten too far ahead of themselves?Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!